EP1144632A3 - Composes destines a l'immunotherapie et au diagnostic du cancer du colon et methodes d'utilisation - Google Patents
Composes destines a l'immunotherapie et au diagnostic du cancer du colon et methodes d'utilisationInfo
- Publication number
- EP1144632A3 EP1144632A3 EP99967625A EP99967625A EP1144632A3 EP 1144632 A3 EP1144632 A3 EP 1144632A3 EP 99967625 A EP99967625 A EP 99967625A EP 99967625 A EP99967625 A EP 99967625A EP 1144632 A3 EP1144632 A3 EP 1144632A3
- Authority
- EP
- European Patent Office
- Prior art keywords
- immunotherapy
- diagnosis
- compounds
- methods
- colon cancer
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Zoology (AREA)
- Biophysics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Animal Behavior & Ethology (AREA)
- General Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Toxicology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Gastroenterology & Hepatology (AREA)
- Biochemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Priority Applications (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP06002432A EP1715043A3 (fr) | 1998-12-23 | 1999-12-23 | Composes destines a l'immunotherapie et au diagnostic du cancer du colon et methodes d'utilisation |
EP06025304A EP1767636A3 (fr) | 1998-12-23 | 1999-12-23 | Composés destinés à l'immunothérapie et au diagnostic du cancer du colon et méthodes d'utilisation |
Applications Claiming Priority (11)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US221298 | 1998-12-23 | ||
US09/221,298 US6284241B1 (en) | 1998-12-23 | 1998-12-23 | Compounds for immunotherapy and diagnosis of colon cancer and methods for their use |
US34749699A | 1999-07-02 | 1999-07-02 | |
US347496 | 1999-07-02 | ||
US09/401,064 US6623923B1 (en) | 1998-12-23 | 1999-09-22 | Compounds for immunotherapy and diagnosis of colon cancer and methods for their use |
US401064 | 1999-09-22 | ||
US444242 | 1999-11-19 | ||
US09/444,242 US6697837B1 (en) | 1999-11-19 | 1999-11-19 | End user profiling method |
US45415099A | 1999-12-02 | 1999-12-02 | |
US454150 | 1999-12-02 | ||
PCT/US1999/030909 WO2000037643A2 (fr) | 1998-12-23 | 1999-12-23 | Composes destines a l'immunotherapie et au diagnostic du cancer du colon et methodes d'utilisation |
Related Child Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EP06025304A Division EP1767636A3 (fr) | 1998-12-23 | 1999-12-23 | Composés destinés à l'immunothérapie et au diagnostic du cancer du colon et méthodes d'utilisation |
EP06002432A Division EP1715043A3 (fr) | 1998-12-23 | 1999-12-23 | Composes destines a l'immunotherapie et au diagnostic du cancer du colon et methodes d'utilisation |
Publications (2)
Publication Number | Publication Date |
---|---|
EP1144632A2 EP1144632A2 (fr) | 2001-10-17 |
EP1144632A3 true EP1144632A3 (fr) | 2001-11-07 |
Family
ID=27539822
Family Applications (3)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EP99967625A Withdrawn EP1144632A3 (fr) | 1998-12-23 | 1999-12-23 | Composes destines a l'immunotherapie et au diagnostic du cancer du colon et methodes d'utilisation |
EP06002432A Withdrawn EP1715043A3 (fr) | 1998-12-23 | 1999-12-23 | Composes destines a l'immunotherapie et au diagnostic du cancer du colon et methodes d'utilisation |
EP06025304A Withdrawn EP1767636A3 (fr) | 1998-12-23 | 1999-12-23 | Composés destinés à l'immunothérapie et au diagnostic du cancer du colon et méthodes d'utilisation |
Family Applications After (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EP06002432A Withdrawn EP1715043A3 (fr) | 1998-12-23 | 1999-12-23 | Composes destines a l'immunotherapie et au diagnostic du cancer du colon et methodes d'utilisation |
EP06025304A Withdrawn EP1767636A3 (fr) | 1998-12-23 | 1999-12-23 | Composés destinés à l'immunothérapie et au diagnostic du cancer du colon et méthodes d'utilisation |
Country Status (6)
Country | Link |
---|---|
EP (3) | EP1144632A3 (fr) |
JP (1) | JP2002533082A (fr) |
AU (1) | AU2387900A (fr) |
CA (1) | CA2356987A1 (fr) |
HK (1) | HK1041025A1 (fr) |
WO (1) | WO2000037643A2 (fr) |
Families Citing this family (26)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6358508B1 (en) | 1997-06-11 | 2002-03-19 | Human Genome Sciences, Inc. | Antibodies to human tumor necrosis factor receptor TR9 |
US6949339B1 (en) | 1998-05-21 | 2005-09-27 | Diadexus, Inc. | Method of diagnosing, monitoring, and staging colon cancer |
US6623923B1 (en) | 1998-12-23 | 2003-09-23 | Corixa Corporation | Compounds for immunotherapy and diagnosis of colon cancer and methods for their use |
US6962779B1 (en) | 1998-10-02 | 2005-11-08 | Diadexus, Inc. | Method of diagnosing, monitoring, staging, imaging and treating gastrointestinal cancers |
CA2350776C (fr) | 1998-11-10 | 2011-05-03 | Emory University | Nouveaux regulateurs mitogeniques |
US6969518B2 (en) | 1998-12-28 | 2005-11-29 | Corixa Corporation | Compositions and methods for the therapy and diagnosis of breast cancer |
US7598226B2 (en) | 1998-12-28 | 2009-10-06 | Corixa Corporation | Compositions and methods for the therapy and diagnosis of breast cancer |
EP1190051A2 (fr) * | 1999-06-17 | 2002-03-27 | Incyte Genomics, Inc. | Proteines de transport humaines |
EP1248800A2 (fr) | 1999-11-30 | 2002-10-16 | Corixa Corporation | Compositions et methodes destinees au traitement et au diagnostic du cancer du sein |
AU2608201A (en) * | 1999-12-30 | 2001-07-16 | Corixa Corporation | Compounds for immunotherapy and diagnosis of colon cancer and methods for their use |
US20020068288A1 (en) * | 2000-04-11 | 2002-06-06 | Lodes Michael J. | Compositions and methods for the therapy and diagnosis of lung cancer |
EP1661995A1 (fr) * | 2000-05-26 | 2006-05-31 | Diadexus, Inc. | Procédé permettant de diagnostiquer, de surveiller, de stadifier, de visualiser et de traiter le cancer du colon |
US6635750B1 (en) | 2000-07-20 | 2003-10-21 | Millennium Pharmaceuticals, Inc. | B7-H2 nucleic acids, members of the B7 family |
EP1307556A2 (fr) * | 2000-08-03 | 2003-05-07 | Corixa Corporation | Compositions et methodes utilisees dans la therapie et le diagnostic du cancer du colon |
WO2002012280A2 (fr) * | 2000-08-03 | 2002-02-14 | Corixa Corporation | Compositions et procedes pour le diagnostic et le traitement du cancer du colon |
US20020142957A1 (en) * | 2000-08-07 | 2002-10-03 | Hepler William T. | Compositions and methods for the therapy and diagnosis of colon cancer |
JP2004528810A (ja) * | 2000-10-02 | 2004-09-24 | バイエル コーポレーション | 癌組織でディファレンシャルに発現される核酸配列 |
AU2002257266A1 (en) * | 2001-05-17 | 2002-11-25 | Pe Corporation (Ny) | Isolated human secreted proteins, nucleic acid molecules encoding human secreted proteins, and uses thereof |
AU2002332606A1 (en) * | 2001-08-21 | 2003-03-24 | Corixa Corporation | Compositions and methods for the therapy and diagnosis of colon cancer |
EP2325335A3 (fr) * | 2001-09-14 | 2012-01-25 | Clinical Genomics Pty. Ltd | Marqueurs d'acides nucléiques pour l'utilisation dans la détermination de la prédisposition au néoplasme et/ou à l'adénome |
WO2003097872A2 (fr) * | 2002-05-21 | 2003-11-27 | Mtm Laboratories Ag | Procede in-vitro permettant de detecter des lesions colorectales |
EP1365242A1 (fr) * | 2002-05-21 | 2003-11-26 | MTM Laboratories AG | Composés pour le diagnostique et le traitement de lésions colorectales |
KR100568755B1 (ko) * | 2003-04-03 | 2006-04-07 | 주식회사 리젠 바이오텍 | Yh 모티프를 포함하는 펩타이드를 유효성분으로함유하는 혈관신생 억제제 |
EP2311468B1 (fr) | 2003-08-08 | 2014-01-15 | Perseus Proteomics Inc. | Gène surexprimé dans le cancer |
DE10341812A1 (de) * | 2003-09-10 | 2005-04-07 | Ganymed Pharmaceuticals Ag | Differentiell in Tumoren exprimierte Genprodukte und deren Verwendung |
EP2123758A1 (fr) * | 2008-05-20 | 2009-11-25 | Wageningen Universiteit | Séquence de tête coiffée ("CAP leader sequence") du virus de la grippe |
Family Cites Families (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1998054963A2 (fr) * | 1997-06-06 | 1998-12-10 | Human Genome Sciences, Inc. | 207 proteines secretees humaines |
WO1999001020A2 (fr) * | 1997-07-01 | 1999-01-14 | Human Genome Sciences, Inc. | 19 proteines secretees humaines |
WO1998039448A2 (fr) * | 1997-03-07 | 1998-09-11 | Human Genome Sciences, Inc. | 186 nouvelles proteines secretees |
US6333152B1 (en) * | 1997-05-21 | 2001-12-25 | The Johnshopkins University | Gene expression profiles in normal and cancer cells |
DE19817557A1 (de) * | 1998-04-09 | 1999-10-21 | Metagen Gesellschaft Fuer Genomforschung Mbh | Menschliche Nukleinsäuresequenzen aus Ovartumorgewebe |
DE19820190A1 (de) * | 1998-04-28 | 1999-11-04 | Metagen Gesellschaft Fuer Genomforschung Mbh | Menschliche Nukleinsäuresequenzen aus Pankreas-Tumor |
EP1080227B1 (fr) * | 1998-05-21 | 2006-02-08 | Diadexus, Inc. | Procédé de diagnostic, de surveillance et de détermination du stade du cancer du colon |
CA2328895A1 (fr) * | 1998-06-02 | 1999-12-09 | Genentech, Inc. | Proteines membranaires et acides nucleiques codant ces proteines |
DK1185648T3 (da) * | 1999-06-02 | 2007-07-30 | Genentech Inc | Fremgangsmåder og sammensætninger til inhibition af neoplastisk cellevækst |
AU3774300A (en) * | 1999-06-02 | 2000-12-18 | Genentech Inc. | Secreted and transmembrane polypeptides and nucleic acids encoding the same |
EP1244695A2 (fr) * | 1999-12-10 | 2002-10-02 | Incyte Genomics, Inc. | Matrice extracellulaire et molecules d'adherence cellulaire |
-
1999
- 1999-12-23 CA CA002356987A patent/CA2356987A1/fr not_active Abandoned
- 1999-12-23 EP EP99967625A patent/EP1144632A3/fr not_active Withdrawn
- 1999-12-23 EP EP06002432A patent/EP1715043A3/fr not_active Withdrawn
- 1999-12-23 JP JP2000589697A patent/JP2002533082A/ja active Pending
- 1999-12-23 EP EP06025304A patent/EP1767636A3/fr not_active Withdrawn
- 1999-12-23 AU AU23879/00A patent/AU2387900A/en not_active Abandoned
- 1999-12-23 WO PCT/US1999/030909 patent/WO2000037643A2/fr active Application Filing
-
2002
- 2002-04-17 HK HK02102895.0A patent/HK1041025A1/zh unknown
Also Published As
Publication number | Publication date |
---|---|
EP1767636A2 (fr) | 2007-03-28 |
AU2387900A (en) | 2000-07-12 |
JP2002533082A (ja) | 2002-10-08 |
EP1715043A2 (fr) | 2006-10-25 |
EP1144632A2 (fr) | 2001-10-17 |
WO2000037643A2 (fr) | 2000-06-29 |
WO2000037643A3 (fr) | 2001-08-09 |
CA2356987A1 (fr) | 2000-06-29 |
EP1715043A3 (fr) | 2007-01-10 |
EP1767636A3 (fr) | 2007-06-13 |
HK1041025A1 (zh) | 2002-06-28 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU2387900A (en) | Compounds for immunotherapy and diagnosis of colon cancer and methods for their use | |
AU2010699A (en) | Compounds for immunotherapy and diagnosis of breast cancer and methods for theiruse | |
AU2001268259A1 (en) | Compositions and methods for the therapy and diagnosis of colon cancer | |
AU2001269766A1 (en) | Compositions and methods for the therapy and diagnosis of colon cancer | |
AU2002251844A1 (en) | Compositions and methods for the therapy and diagnosis of colon cancer | |
IL131560A0 (en) | Compounds for immunotherapy of prostate cancer and methods for their use | |
AU2766399A (en) | Compounds and methods for immunotherapy and diagnosis of tuberculosis | |
AU4185100A (en) | Compounds for therapy and diagnosis of lung cancer and methods for their use | |
AU4473596A (en) | Methods of human prostate cancer diagnosis | |
AU6468998A (en) | Compositions and method for the early diagnosis of ovarian cancer | |
AU2001280982A1 (en) | Compositions and methods for the therapy and diagnosis of colon cancer | |
AU2608201A (en) | Compounds for immunotherapy and diagnosis of colon cancer and methods for their use | |
AU7484800A (en) | Imaging of scattering media using relative detector values | |
AU3105700A (en) | Methods for detection of antiestrogen-resistant breast cancer | |
AU1465801A (en) | Methods for cancer prognosis and diagnosis | |
AU2001252945A1 (en) | Compositions and methods for therapy and diagnosis of colon cancer | |
AU1575697A (en) | Compositions and methods for the treatment and diagnosis of cancer | |
AU2002246519A1 (en) | Compositions and methods for the therapy and diagnosis of colon cancer | |
PL350890A1 (en) | Compounds for immunotherapy and diagnosis of breast cancer and methods for their use | |
AU6062900A (en) | Substituted indole compounds and their use for the treatment of cancer | |
AU2001290518A1 (en) | Compositions and methods for the therapy and diagnosis of colon cancer | |
AU4150999A (en) | Method and kit for early diagnosis of cancer | |
AU2003218208A1 (en) | Methods for diagnosis and prognosis of cancer | |
AU9689398A (en) | Compounds and methods for immunotherapy and immunodiagnosis of prostate cancer | |
AU2001266790A1 (en) | Compositions and methods for the therapy and diagnosis of colon cancer |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PUAI | Public reference made under article 153(3) epc to a published international application that has entered the european phase |
Free format text: ORIGINAL CODE: 0009012 |
|
PUAK | Availability of information related to the publication of the international search report |
Free format text: ORIGINAL CODE: 0009015 |
|
17P | Request for examination filed |
Effective date: 20010713 |
|
AK | Designated contracting states |
Kind code of ref document: A2 Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE |
|
AX | Request for extension of the european patent |
Free format text: AL;LT;LV;MK;RO;SI |
|
XX | Miscellaneous (additional remarks) |
Free format text: DERZEIT SIND DIE WIPO-PUBLIKATIONSDATEN A3 NICHT VERFUEGBAR. |
|
AK | Designated contracting states |
Kind code of ref document: A3 Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE |
|
AX | Request for extension of the european patent |
Free format text: AL;LT;LV;MK;RO;SI |
|
RIN1 | Information on inventor provided before grant (corrected) |
Inventor name: WA, YUQIU, JIANG ,KENT Inventor name: WANG, TONGTONG Inventor name: STOLK, JOHN Inventor name: MEAGHER, MADELEINE, JOY Inventor name: BENSON, DARIN, R. Inventor name: SECRIST, HEATHER Inventor name: LODES, MICHAEL, J. Inventor name: XU, JIANGCHUN |
|
17Q | First examination report despatched |
Effective date: 20050530 |
|
17Q | First examination report despatched |
Effective date: 20050530 |
|
REG | Reference to a national code |
Ref country code: HK Ref legal event code: WD Ref document number: 1041025 Country of ref document: HK |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN |
|
18D | Application deemed to be withdrawn |
Effective date: 20090701 |